World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
128
Citations
91191
World Ranking
2649
National Ranking
1481

John F. DiPersio publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where John F. DiPersio sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 1,126 publications — 96th percentile

96% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

John F. DiPersio D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where John F. DiPersio sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 128 D-Index — 87th percentile

87% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Research.com Recognitions

  • Member of the Association of American Physicians
  • Member of the Association of American Physicians

Overview

John F. DiPersio is affiliated with Washington University in St. Louis in the United States. Their research primarily focuses on medicine, with extensive publications in hematology, oncology, immunology, molecular biology, and genetics.

The scientist's work covers several main topics, including:

  • CAR-T cell therapy research
  • Acute Myeloid Leukemia Research
  • Hematopoietic Stem Cell Transplantation
  • Multiple Myeloma Research and Treatments
  • Immune Cell Function and Interaction
  • Chronic Myeloid Leukemia Treatments
  • Cancer Genomics and Diagnostics

John F. DiPersio has been a frequent contributor to several scientific venues. Most notably, they have published extensively in:

  • Blood
  • Transplantation and Cellular Therapy
  • Blood Advances
  • Clinical Lymphoma Myeloma & Leukemia
  • bioRxiv (Cold Spring Harbor Laboratory)

Their most cited recent papers include:

  • The menin inhibitor revumenib in KMT2A-rearranged or NPM1-mutant leukaemia (2023, Nature)
  • Flotetuzumab as salvage immunotherapy for refractory acute myeloid leukemia (2020, Blood)
  • Genome Sequencing as an Alternative to Cytogenetic Analysis in Myeloid Cancers (2021, New England Journal of Medicine)
  • CAR-modified memory-like NK cells exhibit potent responses to NK-resistant lymphomas (2020, Blood)
  • Immune landscapes predict chemotherapy resistance and immunotherapy response in acute myeloid leukemia (2020, Science Translational Medicine)

The scientist has collaborated extensively with other researchers, including frequent coauthors:

  • Michael P. Rettig
  • Julie Ritchey
  • Matthew Cooper
  • Armin Ghobadi
  • Geoffrey L. Uy

John F. DiPersio's work has also been recognized with professional honors such as membership in the Association of American Physicians.

In addition to articles, they have contributed to academic books, including a publication with Springer International Publishing titled Gene and Cellular Immunotherapy for Cancer in 2022.

Best Publications

  • Genomic and epigenomic landscapes of adult de novo acute myeloid leukemia

    Timothy J. Ley;Christopher Miller;Li Ding;Benjamin J. Raphael

  • Oncogenic Signaling Pathways in The Cancer Genome Atlas

    Francisco Sanchez-Vega;Marco Mina;Joshua Armenia;Walid K. Chatila

  • ASTCT Consensus Grading for Cytokine Release Syndrome and Neurologic Toxicity Associated with Immune Effector Cells

    Daniel W. Lee;Bianca D. Santomasso;Frederick L. Locke;Armin Ghobadi

  • Recurring mutations found by sequencing an acute myeloid leukemia genome.

    Elaine R. Mardis;Li Ding;David J. Dooling;David E. Larson

  • Cell-of-Origin Patterns Dominate the Molecular Classification of 10,000 Tumors from 33 Types of Cancer.

    Katherine A. Hoadley;Christina Yau;Christina Yau;Toshinori Hinoue;Denise M. Wolf

  • Comprehensive Characterization of Cancer Driver Genes and Mutations.

    Matthew H Bailey;Collin Tokheim;Eduard Porta-Pardo;Sohini Sengupta

  • Clonal evolution in relapsed acute myeloid leukaemia revealed by whole-genome sequencing

    Li Ding;Timothy J. Ley;David E. Larson;Christopher A. Miller

  • DNMT3A Mutations in Acute Myeloid Leukemia

    Timothy J. Ley;Li Ding;Matthew J. Walter;Michael D. McLellan

  • A Double-Blind, Placebo-Controlled Trial of Ruxolitinib for Myelofibrosis

    Srdan Verstovsek;Ruben A. Mesa;Jason Gotlib;Richard S. Levy

  • Age-related mutations associated with clonal hematopoietic expansion and malignancies

    Mingchao Xie;Charles Lu;Jiayin Wang;Michael D McLellan

  • Decitabine improves patient outcomes in myelodysplastic syndromes: results of a phase III randomized study.

    Hagop Kantarjian;Jean-Pierre J. Issa;Craig S. Rosenfeld M.D.;John M. Bennett

  • The origin and evolution of mutations in acute myeloid leukemia.

    John S. Welch;Timothy J. Ley;Daniel C. Link;Christopher A. Miller

  • DNA sequencing of a cytogenetically normal acute myeloid leukaemia genome

    Timothy J. Ley;Elaine R. Mardis;Li Ding;Bob Fulton

  • A Phase 2 Trial of Ponatinib in Philadelphia Chromosome–Positive Leukemias

    Jorge E. Cortes;D. W. Kim;J. Pinilla-Ibarz;P. Le Coutre

  • Genomic and Functional Approaches to Understanding Cancer Aneuploidy

    Alison M. Taylor;Alison M. Taylor;Juliann Shih;Gavin Ha;Gavin Ha;Galen F. Gao

  • Clonal Architecture of Secondary Acute Myeloid Leukemia

    Matthew J. Walter;Dong Shen;Li Ding;Jin Shao

  • Phase III prospective randomized double-blind placebo-controlled trial of plerixafor plus granulocyte colony-stimulating factor compared with placebo plus granulocyte colony-stimulating factor for autologous stem-cell mobilization and transplantation for patients with non-Hodgkin's lymphoma.

    John F. DiPersio;Ivana N. Micallef;Patrick J. Stiff;Brian J. Bolwell

  • TP53 and Decitabine in Acute Myeloid Leukemia and Myelodysplastic Syndromes

    John S. Welch;Allegra A. Petti;Christopher A. Miller;Catrina C. Fronick

  • Plerixafor and G-CSF versus placebo and G-CSF to mobilize hematopoietic stem cells for autologous stem cell transplantation in patients with multiple myeloma

    John F. DiPersio;Edward A. Stadtmauer;Auayporn Nademanee;Ivana N.M. Micallef

  • Role of TP53 mutations in the origin and evolution of therapy-related acute myeloid leukaemia

    Terrence N. Wong;Giridharan Ramsingh;Andrew L. Young;Christopher A. Miller

Frequent Co-Authors

Peter Westervelt
Peter Westervelt Brown University
Ravi Vij
Ravi Vij Washington University in St. Louis
Timothy J. Ley
Timothy J. Ley Washington University in St. Louis
Daniel C. Link
Daniel C. Link Washington University in St. Louis
Robert S. Fulton
Robert S. Fulton Washington University in St. Louis
Elaine R. Mardis
Elaine R. Mardis The Ohio State University
Feng Gao
Feng Gao Linköping University
feng gao
feng gao Duke University
Li Ding
Li Ding Washington University in St. Louis
Richard K. Wilson
Richard K. Wilson Nationwide Children's Hospital

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Considering a career in medicine or healthcare? There are several flexible pathways to get started, even if you're looking for online options. Many students today choose to earn a health information management degree online. This degree focuses on the critical intersection of healthcare, technology, and data, preparing graduates for roles in hospitals, clinics, and insurance providers.

If you’re interested in administrative healthcare roles, learning about medical billing and coding certification cost is a great first step. Certification can often be completed quickly and affordably, opening doors to remote and entry-level positions.

Students aiming to become advanced practice nurses may explore the cheapest online fnp program. Family Nurse Practitioner (FNP) programs online are an efficient route for RNs who want to provide primary care.

For those pursuing a more general nursing path, attending nursing school online offers flexibility and lower costs compared to many on-campus programs. These online pathways allow you to join the healthcare workforce while balancing study with work or family commitments.

Best Scientists Citing John F. DiPersio

Trending Scientists

Recently Published Articles